Horizon Therapeutics Said Near Deal to Buy Nitec Pharma AG

Bloomberg -- Horizon Therapeutics Inc., a U.S. developer of pain medications, is close to an agreement to buy Switzerland’s Nitec Pharma AG, said a person with knowledge of the transaction.

MORE ON THIS TOPIC